Search Results - "Martín, Ana Manuela"

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis by Sereno, María, Jimenez-Gordo, Ana María, Baena-Espinar, Javier, Aguado, Carlos, Mielgo, Xabier, Pertejo, Ana, Álvarez-Álvarez, Rosa, Sánchez, Ana, López, Jose Luis, Molina, Raquel, López-Alfonso, Ana, Hernández, Berta, Chiara, Luis Enrique, Martín, Ana Manuela, López-Martín, Ana, Dorta, Miriam, Collazo-Lorduy, Ana, Casado, Enrique, de Molina, Ana Ramirez, Colmenarejo, Gonzalo

“…Background: Approximately 15% of patients infected by SARS-CoV-2 develop a distress syndrome secondary to a host hyperinflammatory response induced by a…”
Get full text

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group by Cánovas, Manuel Sánchez, Garay, David Fernández, Moran, Laura Ortega, Pérez, Jaime Rubio, Rubio, Carlos Miguel Guirao, de Mena, Miriam Lobo, Portero, Berta Obispo, Castro, Jesús Brenes, Lage, Yolanda, Lavin, Diego Cacho, Blanco, Ana Belen Rupérez, de Soignie, Ana Manuela Martín Fernández, Perejón, Jonatan Zacarías Benoit, Colomo, Laura Jiménez, Boluda, Noel Blaya, Moreno, Javier Bosque, Verduguez, Teresa Quintanar, Garrido, Carmen Rosa, Huertas, Roberto Martín, Puig, Carme Font i, Martín, Andrés Jesús Muñoz

“…Purpose Immune Checkpoint Inhibitors (ICI) can be associated with thrombotic events, both venous and arterial (VTE/AT). However, there is a paucity of…”
Get full text

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group by Sánchez Cánovas, Manuel, Fernández Garay, David, Gómez Martínez, Francisco, Brozos Vázquez, Elena, Lobo de Mena, Miriam, García Adrián, Silvia, Pacheco-Barcía, Vilma, Cacho Lavin, Diego, Martínez de Castro, Eva, Martín Fernández de Soignie, Ana Manuela, Martínez, Elia, Rúperez Blanco, Ana Belén, García Escobar, Ignacio, Salvador Coloma, Carmen, Blaya Boluda, Noel, Guirao García, María Esperanza, Gambín Arroniz, Mariano, Muñoz Martín, Andrés J.

“…Purpose The CoVID-TE model was developed with the aim of predicting venous thrombotic events (VTE) in cancer patients with Sars-Cov-2 infection. Moreover, it…”
Get full text

Humanización en la comunicación de malas noticias en el paciente oncológico y paliativo by Solana López, Irene, Juez Martel, Ignacio, Martínez Moreno, Elia, De Zea Luque, Carlos, Martín Fernández de Soignie, Ana Manuela, Sánchez Baños, Nadia, Guerra Martínez, Juan Antonio

“…La comunicación de malas noticias, si bien supone un momento de importante vulnerabilidad para el paciente y sus allegados, es un acto necesario para una…”
Get full text

A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 infection optionally treated with granulocyte colony-stimulating factor (G-CSF) by Jimenez Gordo, Ana M., Colmenarejo, Gonzalo, Baena Espinar, Javier, Aguado, Carlos, Mielgo, Xabier, Pertejo, Ana, Alvarez Alvarez, Rosa Maria, Sanchez, Ana, Lopez, Jose Luis, Molina, Raquel, López-Alfonso, Ana, Hernandez, Berta, Chara Velarde, Luis Enrique, Martin, Ana Manuela, Lopez, Ana, Dorta, Miriam, Lorduy, Ana Collazo, Zambrana, Francisco, Casado, Enrique, Sereno, Maria

“…Abstract only 12105 Background: Infection by SARS-CoV-2 can turn into an acute respiratory infection. Approximately 15% of patients will develop a distress…”
Get full text

Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group by Sánchez Cánovas, Manuel, Fernández Garay, David, Adoamnei, Evdochia, Guirao García, Esperanza, López Robles, Javier, Cacho Lavin, Diego, Martínez de Castro, Eva, Campos Balea, Begoña, Garrido Fernández, Alberto, Fernández Pérez, Isaura, Ferrández Arias, Asia, Suarez, Noelia, Quintanar Verduguez, Teresa, Lobo de Mena, Miriam, Rodríguez, Laura, Gutierrez, David, Martín Fernández de Soiginie, Ana Manuela, García Adrián, Silvia, Ferrer Pérez, Ana Isabel, Delgado Heredia, María Jesús, Muñoz Lerma, Amelia, Luque, Raquel, Mazariegos Rubí, Manuel, Rúperez Blanco, Ana Belen, García Escobar, Ignacio, Mendiola, Jaime, Muñoz Martín, Andrés Jesús

“…Purpose Both venous and arterial thrombotic events (VTE/AT) can be associated with immune checkpoint inhibitors (ICI). However, there is a paucity of…”
Get full text

Supervivencia extendida con pembrolizumab en un paciente con cáncer de pulmón no microcítico estadio IV by Isabel Santana Gómez, Beatriz Losada Vila, David Gutiérrez Abad, Ana Manuela Martin Fernández de Soignie, Irene Solana López, Carlos de Zea Luque, Fátima Escalona Martin, Juan Antonio Guerra Martínez

“…Introducción: La inmunoterapia con pembrolizumab ha mejorado el pronóstico del cáncer de pulmón metastásico. En el presente caso se presenta la supervivencia…”
Get full text

Analizando el protocolo SPIKES desde la perspectiva del paciente oncológico: Estudio prospectivo basado en cuestionarios by Solana Lopez, Irene, Meilan Uzcategui, Manuel, Martínez Moreno, Elia, Juez Martel, Ignacio, Gutiérrez Abad, David, Lahoz León, Elena, Mateo Rodríguez, Olga, Martínez Moreno, Jaime, De Zea Luque, Carlos, Martín Fernández de Soignie, Ana Manuela, Escalona Martín, Fatima, Santana Gómez, Isabel, Guerra Martínez, Juan Antonio

“…Introducción: Establecer una adecuada comunicación forma parte del proceso terapéutico y del abordaje integral del paciente oncológico. El protocolo SPIKES…”
Get full text

Supervivencia extendida con pembrolizumab en un paciente con cáncer de pulmón no microcítico estadio IV: Reporte de caso by Santana Gómez, Isabel, Losada Vila, Beatriz, Gutiérrez Abad, David, Martin Fernández de Soignie, Ana Manuela, Solana López, Irene, De Zea Luque, Carlos, Escalona Martin, Fátima, Guerra Martínez, Juan Antonio

“…Introducción: La inmunoterapia con pembrolizumab ha mejorado el pronóstico del cáncer de pulmón metastásico. En el presente caso se presenta la supervivencia…”
Get full text